V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016122 | 160013215 | 1.58 | 60.8 | Curative (C) | null | 2019-04-13 | ETOPOSIDE | 02 | null | RUCAPARIB | 100365512 |
| 160016124 | 160013216 | 1.66 | 100.2 | Curative (C) | 2018-06-07 | 2018-07-06 | EW EuroEwing 2012 Arm B IE | 2 | N | ETOP 13-18 BEAT-MESO TRIAL | 101007495 |
| 160016126 | 160013217 | 1.78 | 69.9 | Adjuvant (A) | 2019-11-19 | 2019-12-11 | Ifosfamide | 02 | N | GEMCITABINE | 100019798 |
| 160016128 | 160013218 | 1.71 | 82 | Palliative (P) | 2020-06-11 | 2020-06-20 | Etoposide oral | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 101536348 |
| 160016131 | 160013219 | 0 | 57.7 | Curative (C) | 2016-12-18 | 2017-01-07 | Olaparib | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101315991 |
| 160016132 | 160013220 | 0 | 52.35 | Curative (C) | 2019-03-26 | 2019-04-24 | Ifosfamide | 2 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100122559 |
| 160016143 | 160013221 | 1.43 | 61.9 | Curative (C) | 2017-10-29 | 2017-12-21 | Dacarbazine | 02 | N | TRIAL | 101844682 |
| 160016150 | 160013222 | 1.6 | 47.7 | null | 2019-12-03 | 2019-12-04 | VIDE | 02 | null | EW EUROEWING 2012 ARM B IE | 100373278 |
| 160016154 | 160013223 | 1.71 | 78.2 | null | 2016-11-01 | 2016-11-01 | Ipilimumab | null | null | CARBOPLATIN + VINORELBINE | 100806339 |
| 160016155 | 160013224 | 1.78 | 15.3 | Curative (C) | 2020-05-24 | 2020-07-13 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | IVADO | 100008589 |
| 160016159 | 160013225 | null | null | Palliative (P) | 2016-09-04 | 2016-12-24 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100202740 |
| 160016161 | 160013226 | 1.8 | 114.6 | null | 2017-08-28 | 2017-12-09 | Gemcitabine day 1&8 | 02 | null | EW EUROEWING 2012 ARM B IE | 101075740 |
| 160016164 | 160013227 | 1.62 | 110 | null | 2019-04-05 | 2019-04-05 | Cyclophosphamide PO +Vinorelbine IV | 02 | null | PEMBROLIZUMAB | 101808165 |
| 160016166 | 160013228 | null | null | null | 2017-12-04 | 2018-12-20 | EW EuroEwing 2012 Arm B IE | N | null | OLAPARIB | 100421690 |
| 160016170 | 160013229 | 0 | 71.6 | Palliative (P) | 2020-03-26 | 2020-05-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | BENDAMUSTINE + RITUXIMAB | 100415905 |
| 160016172 | 160013230 | 1.61 | 85.2 | Palliative (P) | 2016-08-23 | 2016-09-04 | GEMCITABINE | 02 | N | PEMBROLIZUMAB | 101857592 |
| 160016177 | 160013231 | 0 | 79 | Curative (C) | 2017-05-03 | 2017-05-03 | IVA | 02 | N | RMS 2005 TRIAL | 100223707 |
| 160016178 | 160013232 | 1.62 | 14 | Palliative (P) | 2016-09-20 | 2016-09-27 | null | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100892173 |
| 160016182 | 160013233 | 1.67 | null | null | 2019-08-21 | 2019-08-22 | EW EuroEwing 2012 Arm B IE | 02 | null | IFOSFAMIDE | 101057979 |
| 160016183 | 160013234 | 0 | 75 | null | 2017-06-20 | 2017-11-11 | Ribociclib | 02 | null | NIRAPARIB | 100705666 |
| 160016189 | 160013235 | 0 | 75.3 | Palliative (P) | 2017-05-19 | 2017-05-19 | EW EuroEwing 2012 Arm A VAC | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100636353 |
| 160016198 | 160013239 | 1.8 | 12.9 | Palliative (P) | 2017-10-21 | 2017-10-30 | EW EuroEwing 2012 Arm B VC | 01 | N | PEMBROLIZUMAB | 100051458 |
| 160016202 | 160013240 | 1.89 | 19.6 | null | 2019-09-28 | 2019-10-14 | VINCRISTINE | 02 | null | LUTETIUM-177 | 100245376 |
| 160016203 | 160013241 | 1.74 | 62.2 | null | 2020-11-01 | 2020-11-02 | CAPECITABINE + OXALIPLATIN | 01 | null | DOXORUBICIN + IFOSFAMIDE | 101031665 |
| 160016204 | 160013242 | 1.66 | 58.8 | Curative (C) | 2015-10-06 | 2015-10-27 | ETOP 13-18 BEAT-meso Trial | N | N | EW EUROEWING 2012 ARM A VAI | 101284717 |
| 160016207 | 160013243 | 1.63 | 80.15 | null | 2016-07-18 | 2016-10-22 | MELPHALAN | 02 | null | VENETOCLAX | 101420014 |
| 160016208 | 160013244 | 1.56 | 71 | null | 2016-07-22 | 2016-09-10 | Carboplatin + Vinorelbine IV &PO D8 | 02 | N | ATOMIC-MESO TRIAL | 101453452 |
| 160016209 | 160013245 | 0 | 74 | null | 2020-07-12 | 2020-07-25 | Niraparib | 02 | null | IFOSFAMIDE | 100261378 |
| 160016213 | 160013247 | 1.63 | 9.6 | null | 2019-05-02 | 2019-05-02 | Trial Unspecified | 02 | null | VAI | 100339011 |
| 160016214 | 160013248 | 1.73 | 66 | Palliative (P) | 2017-10-31 | 2017-12-12 | null | N | N | PEMBROLIZUMAB | 100377752 |
| 160016215 | 160013249 | 1.77 | 19.1 | null | 2018-06-01 | 2018-06-01 | Pazopanib | 02 | null | NOT MATCHED | 101711099 |
| 160016216 | 160013250 | 1.59 | 69 | null | 2017-07-21 | 2019-12-31 | CONFIRM TRIAL | 02 | null | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100889867 |
| 160016227 | 160013251 | 0 | 15.8 | Palliative (P) | 2018-08-13 | 2018-08-13 | ARIEL 4 Trial | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100301185 |
| 160016234 | 160013252 | 1.58 | 115.65 | Curative (C) | 2018-09-29 | 2018-09-30 | GEMCITABINE | 2 | N | TRIAL | 101787831 |
| 160016240 | 160013253 | 1.63 | 63 | null | 2020-09-16 | 2020-09-23 | NB Relapsed CCLG guidelines TVD | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100737869 |
| 160016241 | 160013254 | 0.98 | 13.05 | Neo-adjuvant (N) | 2019-02-05 | 2019-02-12 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | NIRAPARIB | 101610471 |
| 160016242 | 160013255 | 1.5 | 13 | Adjuvant (A) | 2020-05-28 | 2020-05-28 | Cyclophosphamide + Topotecan | N | Y | EURO-EWING | 100184758 |
| 160016247 | 160013256 | 0 | 77 | null | 2016-07-14 | 2016-07-15 | Ifosfamide | 2 | null | ERIBULIN | 100757978 |
| 160016250 | 160013257 | 0 | 95.2 | null | null | 2019-03-08 | Doxorubicin + Ifosfamide | 02 | null | OLAPARIB | 101735056 |
| 160016251 | 160013258 | 1.74 | null | Curative (C) | 2019-12-24 | 2020-01-21 | Doxorubicin + Ifosfamide | N | N | VAI | 100455664 |
| 160016262 | 160013259 | 1.14 | 30.3 | Palliative (P) | 2019-12-10 | 2020-02-18 | Rucaparib | 02 | N | GEMCITABINE | 100613752 |
| 160016264 | 160013260 | 1.82 | 85.6 | Palliative (P) | 2016-10-31 | 2016-10-31 | Ifosfamide 3g/m2 5 day | 02 | N | DACARBAZINE | 100463884 |
| 160016268 | 160013262 | 1.72 | 74 | null | 2017-12-15 | 2017-12-15 | GEMCITABINE | 02 | null | IVA | 101200519 |
| 160016271 | 160013263 | 0 | 59.6 | Palliative (P) | 2020-02-18 | 2020-07-20 | ICE + GCSF | 02 | N | GEMCITABINE | 100297163 |
| 160016279 | 160013264 | 1.58 | 114.6 | null | 2019-04-22 | 2019-04-22 | Cyclophosphamide oral | Y | null | IPILIMUMAB + NIVOLUMAB | 100874490 |
| 160016280 | 160013265 | 1.83 | 76.99 | Curative (C) | null | null | Temozolomide 150mg/m2 | 02 | N | PALBOCICLIB | 101433050 |
| 160016282 | 160013266 | 1.51 | 12 | Curative (C) | 2020-04-22 | 2021-01-12 | CONFIRM TRIAL | 02 | N | CARBOPLATIN + ETOPOSIDE | 100190812 |
| 160016283 | 160013267 | 0 | 104 | Curative (C) | 2018-08-08 | 2018-12-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE | 101060221 |
| 160016287 | 160013268 | 1.8 | 76.9 | null | 2018-07-14 | 2018-07-14 | EW EuroEwing 2012 Arm B IE | 02 | null | DABRAFENIB + TRAMETINIB | 101210219 |
| 160016288 | 160013269 | 1.71 | 71.4 | Curative (C) | 2018-12-11 | 2019-01-23 | ICON8B TRIAL | 02 | N | GEMCARBO | 101767558 |